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Access for Transcatheter
Aortic Valve Replacement
Which Is the Preferred Route?*
Michael J. Mack, MD
Dallas, Texas
Transcatheter aortic valve replacement (TAVR) has been
performed in an estimated 50,000 patients worldwide in 46
countries. Significant advancements in delivery techniques
and devices, including lower profile delivery systems and
expandable sheaths have served to decrease the access-
related complication rates while expanding the population
of patients who can safely undergo the procedure (1). There
are multiple avenues for delivery of TAVR devices, includ-
ing the transfemoral (TF) route; transapical (TA) access;
direct aortic (DA) or transaortic; and subclavian or axillary
sites. The antegrade transfemoral venous approach origi-
nally employed by Cribier et al. (2) has been abandoned due
to the facility of the other approaches. In a few extraordinary
cases in which these more common routes have been
precluded, the carotid arteries or conduits sewn onto the
iliac arteries have been used. Each method of delivery access
has advantages and disadvantages both to the patient
receiving the valve as well as to the operator performing the
procedure.
See page 477
The TF method is the most commonly used approach
with over one-half of TAVR devices being deployed by this
approach. Originally performed by a surgical cutdown
technique, most TF procedures are now done using a
percutaneous “pre-closure” technique (1). Major vascular
complications, which occurred not infrequently in the early
years and were associated with a significant mortality, have
become much less of an issue because most local vascular
complications, including dissection, are now able to be
managed by endovascular techniques and the patients most
at risk for complications are now able to be treated by
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Lifesciences.alternative access routes. The advantages of the TF tech-
niques include the fact that it is the least invasive approach,
especially when performed percutaneously and the fact that
it can be performed in most patients with lower profile
(18-F) delivery systems. Disadvantages include inability to
place in patients with small vessel size (6 or 7 mm
depending on the delivery system) and in patients with
significant aorto-iliac occlusive disease. There have also
been concerns raised regarding an increased risk of cerebral
embolization due to transit of the device and delivery system
across the aortic arch, potentially causing atherosclerotic
debris, but the clinically evident stroke risk relative to other
routes that do not transit the aortic arch has not borne out
to a significant degree (3).
The TA approach is the second most common access
route for TAVR. Advantages of this approach include:
1) that virtually all patients are candidates technically for
this approach; and 2) the straight line to the aortic valve,
short delivery distance, and more rigid delivery system
(“valve on a stick” rather than valve on a catheter) all
facilitate accurate valve placement (4). Disadvantages, how-
ever, include the invasiveness of the surgical thoracotomy
necessary for this approach especially in elderly, debilitated
patients and those with significant lung disease. Early
bleeding complications related to cardiac apical tissue fra-
gility have largely disappeared due to refinements and
standardization of apical purse string suturing techniques.
Development of apical access and closure devices promise
the potential of a “percutaneous, trocar-based” TA approach
to provide a secure, less invasive technique.
A technique that has gained a lot of interest and use
recently is the DA approach. Originally developed for use
with the Medtronic CoreValve (Medtronic, Inc., Minneap-
olis, Minnesota) because the longer device profile precluded
use of this valve by the TA approach in patients with TF
access issues, it is now being used more commonly with
both this device as well as the Edwards Sapien (Edwards
Lifesciences, Irvine, California) device (5). The advantage
of the direct aortic approach is the operator friendliness,
which includes direct delivery at a short distance from the
aortic valve through a purse string suture in the ascending
aorta with which all cardiac surgeons are proficient. The
disadvantage, however, is that a surgical incision is still
required, either an upper partial sternotomy or small right
anterior thoracotomy; although both of which arguably may
be less invasive than the incision required for the TA
approach. Concerns have also been raised about the pres-
ence of calcification in the ascending aorta precluding use in
some patients, but heretofore this has not been a major
issue. In this issue of JACC: Cardiovascular Interventions,
Bapat et al. (6) demonstrate that virtually all patients are
candidates for this approach even when ascending aortic
calcification is present.
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488The fourth and least commonly used approach is the
subclavian or axillary artery approach (7). Originally used for
access for the CoreValve devices when the TF approach was
not possible, it appears to be losing favor compared with the
DA approach. Both left and right subclavian arteries have
been used, although the left is used more commonly due to
better delivery angulation relative to the aortic valve. Sur-
geons are very conversant with the subclavian artery for
arterial access, using it frequently with a conduit sewn on to
it as a method for instituting cardiopulmonary bypass
especially when performing surgery on the aortic arch or
when circulatory arrest is performed. Although the artery is
not frequently diseased, it can be relatively small in caliber
and is subject to dissection or disruption on manipulation
due to the relative lack of a muscular component to the
arterial wall. A further concern is use of the left subclavian
in patients with previous coronary artery bypass surgery and
a patent left internal mammary artery due to the possible
risk of occlusion.
The subclavian or axillary access approach performed by a
percutaneous technique is the subject of a study published in
this issue, the so-called “Hamburg Sankt Georg Approach”
(8). The investigators report their experience in 24 patients:
16 performed from the left side and 8 from the right. Two
different vascular closure devices were used with varying
degrees of success. Although no patient required immediate
surgical repair, 7 (29%) patients required an immediate
endovascular stent graft to be placed; 2 (8.3%) patients
required a second procedure due to dissection or stent
thrombosis; and another required a surgical repair of a
brachial artery pseudoaneurysm. Although no patient suf-
fered a major complication according to Valve Academic
Research Consortium (VARC) definitions, 29% did suffer
minor VARC complications (9). The investigators describe
a technique that puts a “safety net” around the procedure
that requires 3 arterial access sites—ipsilateral brachial,
subclavian, and transfemoral—so the axillary artery can be
reliably accessed and so that an occlusion balloon for
proximal control of the subclavian artery at the time of
sheath removal can be placed over an arterio-arterial mono-
rail system.
The investigators are to be congratulated on the innova-
tive techniques they have employed to provide percutaneous
access for TAVR. However, it seems to be a much more
complicated procedure to perform given the facility and
wide use of the alternative access routes now available, iincluding simply a surgical cutdown of the subclavian or
axillary artery, thus violating the principle of keeping it
simple. Although the complication rate was relatively high
in this series, the rate did seem to decrease as the investi-
gators gained more experience. It should be a technique that
all operators are knowledgeable about so that it can be used
when the more widely used and easier to employ access
routes are not available. However, due to the broader
experience, lower complication rate, and operator friendli-
ness of the 3 other access techniques, I would recommend
that this technique remain held in reserve until there are no
other good alternatives.
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